Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar 14;317(10):1015-1016.
doi: 10.1001/jama.2017.0241.

Management of Type 2 Diabetes in 2017: Getting to Goal

Affiliations

Management of Type 2 Diabetes in 2017: Getting to Goal

Jane E B Reusch et al. JAMA. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Reusch reported receiving grant funding from AstraZeneca and Merck; and serving on the board of directors for the American Diabetes Association. No other disclosures were reported.

Figures

Figure
Figure. Glucose Management for Patients With Type 2 Diabetes
DPP4 indicates dipeptidyl peptidase 4 inhibitors; GLP1RA, glucagon-like peptide 1 receptor agonists; HbA1c, hemoglobin A1c; HF, heart failure; MACE, major adverse cardiovascular events; Pio, pioglitazone; SGLT2, sodium glucose transporter 2 inhibitors; and SU, sulfonylureas. aIndicates a higher-cost drug.

References

    1. US Centers for Disease Control and Prevention. Diabetes statistics. http://www.cdc.gov/diabetes/data/statistics/2014statisticsreport.html. Accessed January 4, 2017.
    1. American Diabetes Association. Diabetes statistics. http://www.diabetes.org. Accessed January 4, 2017.
    1. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes, 2015. Diabetes Care. 2015;38(1):140–149. - PubMed
    1. Sherr D, Lipman RD. The diabetes educator and the diabetes self-management education engagement. Diabetes Educ. 2015;41(5):616–624. - PubMed
    1. Holden SE, Jenkins-Jones S, Currie CJ. Association between insulin monotherapy versus insulin plus metformin and the risk of all-cause mortality and other serious outcomes. PLoS One. 2016;11(5):e0153594. - PMC - PubMed

Publication types